New Research Confirms
Why It Matters
The study could reshape prescribing practices, prompting broader hormone testing and targeted replacement to improve longevity and quality of life for aging adults.
Key Takeaways
- •Hormone therapy linked to reduced all‑cause mortality in new study.
- •Adequate testosterone and DHT levels crucial for men's health.
- •Low luteinizing hormone correlates with higher death risk.
- •Bioidentical hormone replacement benefits menopausal women’s vitality and overall health.
- •Regular hormone testing recommended for personalized treatment plans.
Summary
A recently published long‑term study on testosterone and its metabolites challenges two decades of medical orthodoxy that warned against hormone replacement therapy. The research finds that maintaining adequate levels of testosterone, dihydrotestosterone (DHT) and luteinizing hormone (LH) is associated with lower all‑cause mortality for both men and women.
The investigators measured serum testosterone, DHT, and LH in thousands of participants and tracked health outcomes over 25 years. Results show that men with low testosterone or DHT face higher risk of death, while women entering menopause who receive bioidentical hormone replacement experience reduced mortality and improved energy levels. The study also links suppressed LH—an indicator of testicular function—to increased mortality.
One of the study’s authors emphasized, “If you have healthy hormone levels, your risk of dying from everything goes down,” echoing the video’s call to “get your vibe back.” The presentation highlighted personal anecdotes, such as the speaker’s exclamation, “I need it,” to illustrate the tangible benefits of restored libido and muscle mass.
The findings suggest clinicians should reconsider blanket avoidance of hormone therapy and instead adopt individualized testing protocols. For men, routine testosterone screening could become a preventive measure; for women, timely bioidentical hormone replacement may mitigate age‑related decline and lower health‑care costs associated with chronic fatigue and frailty.
Comments
Want to join the conversation?
Loading comments...